NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,338.31% | -57.97% | -502.69% | -- | -- |
| Total Depreciation and Amortization | 24.12% | 2.90% | -10.27% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -367.74% | -379.53% | -392.76% | -- | -- |
| Change in Net Operating Assets | -448.63% | -1,235.90% | -271.68% | -- | -- |
| Cash from Operations | -422.42% | -1,008.86% | -367.93% | -- | -- |
| Capital Expenditure | -32.25% | -5.99% | 24.18% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -747,710.00% | -747,700.00% | -- | -- | -- |
| Cash from Investing | -9,228.91% | -4,951.19% | 24.18% | -- | -- |
| Total Debt Issued | 161.53% | 216.56% | 387.99% | -- | -- |
| Total Debt Repaid | 100.00% | 59.49% | 31.91% | -- | -- |
| Issuance of Common Stock | -33.65% | -33.65% | -33.65% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 175.52% | 169.12% | -226.41% | -- | -- |
| Cash from Financing | 649.35% | 1,474.59% | 361.11% | -- | -- |
| Foreign Exchange rate Adjustments | -370.82% | -373.85% | 337.57% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,233.80% | 1,270.46% | 1,417.67% | -- | -- |